Evidence map›Paper›PMID 16385121›Full record

ArticleMicrobiology (Reading, England)2006

Lipoprotein computational prediction in spirochaetal genomes.

João C Setubal, Marcelo Reis, James Matsunaga, David A Haake

Open access · greenAbstract read
In one paragraph

Article in Microbiology (Reading, England), 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 123 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
123citing papers in PubMed, 1 pooled it
7.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

123 citing papers in PubMed, 1 synthesis or guideline pooled it, 211 citations in OpenAlex.

  1. Trends and advances inFrontiers in microbiology · 2024
    Pooled it
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Serovar-specific genomic features ofFrontiers in molecular biosciences · 2025
    Article
  8. Hitchhiker's Guide toJournal of bacteriology · 2024
    Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. International journal of environmental research and public health · 2023
    Review
  14. Review
  15. Review
  16. Lipoproteome screening of the Lyme disease agent identifies inhibitors of antibody-mediated complement killing.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  17. Article
  18. Development of Human Recombinant Leptospirosis Vaccines.Methods in molecular biology (Clifton, N.J.) · 2022
    Article
  19. Article
  20. Review

63 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

João C SetubalVirginia Bioinformatics Institute, Virginia Tech, Bioinformatics 1, Box 0477, Blacksburg, VA 24060-0477, USA.
Marcelo ReisLaboratório de Bioinformática, Instituto de Computação, Universidade Estadual de Campinas, Caixa Postal 6076, Campinas, SP 13084-071, Brazil.
James MatsunagaDepartment of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095 USA.
David A HaakeDepartment of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095 USA.
University of California, Los Angeles · USUniversidade Estadual de Campinas (UNICAMP) · BRVirginia Tech · US

Funding

Outer Membrane Proteins of Pathogenic Leptospira SpeciesR01AI034431 · NIAID · BRENTWOOD BIOMEDICAL RESEARCH INSTITUTE · PI GOMES-SOLECKI, MARIA, HAAKE, DAVID A · 2003 to 2015
$4.1M
OUTER MEMBRANE PROTEINS OF PATHOGENIC LEPTOSPIRA SPECIESR21AI034431 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI HAAKE, DAVID A · 2001 to 2001
$252k
OUTER MEMBRANE PROTEINS OF PATHOGENIC LEPTOSPIRA SPECIESR29AI034431 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI HAAKE, DAVID A · 1996 to 2000
$91k
NIAID NIH HHS AI-34431NIAID NIH HHS R01 AI034431NIAID NIH HHS R21 AI034431NIAID NIH HHS R29 AI034431
6 · The paper itself

Abstract

Lipoproteins are of great interest in understanding the molecular pathogenesis of spirochaetes. Because spirochaete lipobox sequences exhibit more plasticity than those of other bacteria, application of existing prediction algorithms to emerging sequence data has been problematic. In this paper a novel lipoprotein prediction algorithm is described, designated SpLip, constructed as a hybrid of a lipobox weight matrix approach supplemented by a set of lipoprotein signal peptide rules allowing for conservative amino acid substitutions. Both the weight matrix and the rules are based on a training set of 28 experimentally verified spirochaetal lipoproteins. The performance of the SpLip algorithm was compared to that of the hidden Markov model-based LipoP program and the rules-based algorithm Psort for all predicted protein-coding genes of Leptospira interrogans sv. Copenhageni, L. interrogans sv. Lai, Borrelia burgdorferi, Borrelia garinii, Treponema pallidum and Treponema denticola. Psort sensitivity (13-35 %) was considerably less than that of SpLip (93-100 %) or LipoP (50-84 %) due in part to the requirement of Psort for Ala or Gly at the -1 position, a rule based on E. coli lipoproteins. The percentage of false-positive lipoprotein predictions by the LipoP algorithm (8-30 %) was greater than that of SpLip (0-1 %) or Psort (4-27 %), due in part to the lack of rules in LipoP excluding unprecedented amino acids such as Lys and Arg in the -1 position. This analysis revealed a higher number of predicted spirochaetal lipoproteins than was previously known. The improved performance of the SpLip algorithm provides a more accurate prediction of the complete lipoprotein repertoire of spirochaetes. The hybrid approach of supplementing weight matrix scoring with rules based on knowledge of protein secretion biochemistry may be a general strategy for development of improved prediction algorithms.

Indexed as

AlgorithmsGenes, BacterialLipoproteinsSequence Analysis, ProteinSpirochaetalesLipoproteins

Identifiers

PMID16385121
PMCPMC2667199
OpenAlexW2107943123

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.